Aripiprazole-Induced Enuresis in a Child with Autistic Disorder/Otizm Tanili Bir Cocukta Aripiprazole Bacli Enurezis (Case Study‪)‬

Introduction Aripiprazole anovel atypical antipsychotic, is being administered to children and adolescents for the management of mood instability, aggression, and psychosis. Recently, the U.S. Food and Drug Administration (FDA) has approved it for the treatment of irritability associated with autistic disorder in pediatric patients aged 6-17 years and including symptoms of aggression towards others, deliberate self-injuriousness, temper tantrums, and quickly changing moods (1). Compared to other atypical antipsychotics, aripiprazole is reported to cause fewer side effects e.g., weight gain, elevation in glucose and lipid levels, prolactin elevation, QTc prolongation, and onset of diabetes mellitus. Other untoward events include headache, insomnia, nausea, vomiting, lightheadedness, somnolence, constipation, increased appetite and dyspepsia (2). Here, we present a case of aripiprazole-induced enuresis in an adolescent with autistic disorder.